Investigative Urology - Results from #6900

Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis - Abstract February 22, 2011

Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines - Abstract February 11, 2011

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer - Abstract February 9, 2011

Excision repair cross-complementing group 1 (ERCC1) may predict the efficacy of chemoradiotherapy for bladder cancer - Abstract February 4, 2011

Receptor heterodimerization: A new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer - Abstract February 3, 2011

The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy - Abstract February 3, 2011

FUS/TLS is a novel mediator of androgen-dependent cell cycle progression and prostate cancer growth - Abstract February 3, 2011

A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer - Abstract November 11, 2010

Page 346 of 346